Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study
Creator
Liu, Jian
Liu, Zhirong
Zheng, Xueying
Jin, Tengchuan
Ding, Yu
Ling, Ping
Luo, Sihui
Sun, Yong
Weng, Jianping
Han, Mingfeng
Sun, Liangye
Zhang, Liangming
Source
PMC
abstract
In this population-based study, we identified 307 confirmed COVID-19 cases from massive surveillance, including 129,551 individuals screened at fever clinics or returning from Hubei and 3710 close contacts of confirmed COVID-19 patients. Among them, 17 patients were asymptomatic at initial clinical assessment. These asymptomatic patients on admission accounted for a small proportion of all patients (5.54%) with relatively weak transmissibility, and the detection rate was 0.35 per 100 close contacts. Moreover, the dynamics of symptoms of the 307 patients showed that the interval from symptom remission to the final negativity of viral nucleic acid was 5.0 days (IQR 2.0 to 11.0 days), with 14 patients (4.56%) having re-detectable viral RNA after discharge. Together, our findings suggested asymptomatic carriers and presymptomatic patients only accounted for a small proportion of COVID-19. Also, the asymptomatic phase in during recovery of COVID-19 urged that negativity in viral RNA is necessary as de-isolation criteria and follow-up is recommended.
has issue date
2020-06-23
(
xsd:dateTime
)
bibo:doi
10.1093/nsr/nwaa141
has license
cc-by
sha1sum (hex)
5e8cc1543e2089cb3429ab791a4cd23290335e08
schema:url
https://doi.org/10.1093/nsr/nwaa141
resource representing a document's title
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study
has PubMed Central identifier
PMC7337770
schema:publication
Natl Sci Rev
resource representing a document's body
covid:5e8cc1543e2089cb3429ab791a4cd23290335e08#body_text
is
schema:about
of
named entity 'COVID-19'
named entity 'viral'
named entity 'initial'
named entity 'Disease'
named entity '129'
named entity '0 DAYS'
named entity 'SYMPTOM REMISSION'
named entity 'FEVER'
named entity 'viral'
named entity 'asymptomatic'
named entity 'patients'
named entity 'recovery'
named entity 'COVID-19'
named entity 'remission'
named entity 'contacts'
named entity 'COVID-19'
named entity 'symptom'
named entity 'patients'
named entity '2019'
named entity 'Hubei'
named entity 'COVID'
named entity 'viral RNA'
named entity 'nucleic acid'
named entity 'COVID-19'
named entity 'close'
named entity 'symptoms'
named entity 'SARS-CoV-2'
named entity 'fever'
named entity 'coronavirus'
named entity 'symptom'
named entity 'nucleic acid tests'
named entity 'epidemiological data'
named entity 'fever'
named entity 'asymptomatic carriers'
named entity 'home isolation'
named entity 'chest CT'
named entity 'inflammatory'
named entity 'fever'
named entity 'spread of the disease'
named entity 'Anqing'
named entity 'case report'
named entity 'fever'
named entity 'SARS-CoV-2'
named entity 'viral RNA'
named entity 'RNA'
named entity 'infection'
named entity 'virus'
named entity 'IgM'
named entity 'asymptomatic carriers'
named entity 'C-reactive protein'
named entity 'nucleic acid'
named entity 'asymptomatic'
named entity 'infection'
named entity 'virus'
named entity 'viral RNA'
named entity 'afebrile'
named entity 'Wuhan'
named entity 'public health interventions'
named entity 'COVID'
named entity 'CDC'
named entity 'IgA'
named entity 'interquartile range'
named entity 'COVID'
named entity 'quarantine'
named entity 'hypertension'
named entity 'asymptomatic patients'
named entity 'infection'
named entity 'nucleic acid'
named entity 'preexisting conditions'
named entity 'virus'
named entity 'asymptomatic carriers'
named entity '13.0'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software